Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
BMC Res Notes ; 11(1): 53, 2018 Jan 20.
Artigo em Inglês | MEDLINE | ID: mdl-29352811

RESUMO

OBJECTIVE: ß-Lactamase-negative ampicillin-resistant Haemophilus influenzae is a common opportunistic pathogen of hospital- and community-acquired infections, harboring multiple single nucleotide polymorphisms in the ftsI gene, which codes for penicillin-binding protein-3. The objectives of this study were to perform comprehensive genetic analyses of whole regions of the penicillin-binding proteins in H. influenzae and to identify additional single nucleotide polymorphisms related to antibiotic resistance, especially to ampicillin and other cephalosporins. RESULTS: In this genome analysis of the ftsI gene in 27 strains of H. influenzae, 10 of 23 (43.5%) specimens of group III genotype ß-lactamase-negative ampicillin-resistant H. influenzae were paradoxically classified as ampicillin-sensitive phenotypes. Unfortunately, we could not identify any novel mutations that were significantly associated with ampicillin minimum inhibitory concentrations in other regions of the penicillin-binding proteins, and we reconfirmed that susceptibility to ß-lactam antibiotics was mainly defined by previously reported SNPs in the ftsI gene. We should also consider detailed changes in expression that lead to antibiotic resistance in the future because the acquisition of resistance to antimicrobials can be predicted by the expression levels of a small number of genes.


Assuntos
Ampicilina/farmacologia , Proteínas de Bactérias/genética , Haemophilus influenzae/genética , Proteínas de Ligação às Penicilinas/genética , Polimorfismo de Nucleotídeo Único , Resistência a Ampicilina/genética , Antibacterianos/farmacologia , Genótipo , Infecções por Haemophilus/microbiologia , Haemophilus influenzae/efeitos dos fármacos , Haemophilus influenzae/metabolismo , Humanos , Testes de Sensibilidade Microbiana , beta-Lactamases/metabolismo
2.
J Microbiol Methods ; 141: 108-114, 2017 10.
Artigo em Inglês | MEDLINE | ID: mdl-28807759

RESUMO

Rapid and easy detection of sequence polymorphisms, including nucleotide point mutations of bacterial pathogens responsible for amino acid substitutions linked to drug resistance, is essential for the proper use of antimicrobial agents. Here, a detection method using loop-mediated amplification (LAMP) combined with amplification refractory mutation system (ARMS) to accurately distinguish a different single nucleotide in the target sequence was established, named ARMS-SNP LAMP. This procedure is capable of species-specific detection of a nucleotide (1578T) in the ftsI gene on Haemophilus influenzae without amplifying the sequence carrying the point mutations (T1578G/A) in ß-lactamase-negative ampicillin resistant (BLNAR) strains. Reactions were performed at 61°C for 45min. Successful target gene amplifications were detected by measuring real-time turbidity using a turbidimeter and visual detection. The assay had a detection limit of 10.0pg of genomic DNA per reaction and showed specificity against 52 types of pathogens, whereas amplifications were completely blocked in even 100.0ng/µL of genomic DNA with point mutations at T1578G and T1578A. The expected ARMS-SNP LAMP products were confirmed through identical melting curves in real-time LAMP procedures. This novel procedure was also used to analyze 57 clinical isolates of H. influenzae. All 25 clinical isolates with the naïve sequence of 1578T gave positive results. In addition, concordant negative results were obtained for 31 of the BLNAR strains with the T1578G mutation and one strain with the T1578A mutation. The ARMS-SNP LAMP method is a simple and rapid method for SNP-genotyping of a clinical isolate as point-of-care testing (POCT) technology. It is suitable for use in both resource-limited situations and well-equipped clinical settings because of its simplicity and convenience.


Assuntos
Resistência a Ampicilina/genética , Haemophilus influenzae/genética , Técnicas de Amplificação de Ácido Nucleico/métodos , Proteínas de Ligação às Penicilinas/genética , Mutação Puntual , beta-Lactamases/metabolismo , Ampicilina/farmacologia , Antibacterianos/farmacologia , DNA Bacteriano/genética , Genótipo , Infecções por Haemophilus/microbiologia , Haemophilus influenzae/efeitos dos fármacos , Haemophilus influenzae/enzimologia , Humanos , Limite de Detecção , Testes de Sensibilidade Microbiana , Nefelometria e Turbidimetria , Testes Imediatos , Polimorfismo Genético , Sensibilidade e Especificidade , Temperatura , beta-Lactamases/genética
3.
J Microbiol Methods ; 141: 90-96, 2017 10.
Artigo em Inglês | MEDLINE | ID: mdl-28811193

RESUMO

Rapid and easy detection of a single nucleotide point mutation of bacterial genes, which is directly linked to drug susceptibility, is essential for the proper use of antimicrobial agents. Here, we established a detection method using a peptide nucleic acid mediated loop-mediated amplification (LAMP) assay for macrolide (ML)-susceptible Mycoplasma pneumoniae. This assay specifically detected the absence of missense mutations encoding the central loop of domain V in the gene encoding 23S rRNA, which can reduce the affinity for MLs and subsequently generate ML-resistant strains of M. pneumoniae. Reactions were performed at 62°C for 60min and targeted gene amplifications were detected by real-time turbidity with a turbidimeter and naked-eye inspection of a color change. The assay had an equivalent detection limit of 100.0fg of DNA with the turbidimeter and showed specificity against 54 types of pathogens, whereas amplification was completely blocked, even at 100.0pg of DNA per reaction, in the presence of point mutations at 2063A and 2064A. The expected LAMP products were confirmed through identical melting curves in real-time LAMP procedures. This method would be a simple and rapid protocol for single nucleotide polymorphism genotyping as point-of-care testing technology without amplification of the sequences carrying the point mutations 2063A and 2064A in ML-resistant M. pneumoniae strains.


Assuntos
Genes de RNAr , Mycoplasma pneumoniae/genética , Técnicas de Amplificação de Ácido Nucleico/métodos , Ácidos Nucleicos Peptídicos/genética , Mutação Puntual , RNA Ribossômico 23S/genética , Colorimetria/métodos , DNA Bacteriano/genética , Genes Bacterianos , Genótipo , Humanos , Limite de Detecção , Mycoplasma pneumoniae/isolamento & purificação , Nasofaringe/microbiologia , Pneumonia por Mycoplasma/diagnóstico , Pneumonia por Mycoplasma/microbiologia , Testes Imediatos , Reação em Cadeia da Polimerase/métodos , Sensibilidade e Especificidade , Temperatura
4.
PLoS One ; 10(7): e0133759, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26208001

RESUMO

Bacillus Calmette-Guérin (BCG) is widely used as a live attenuated vaccine against Mycobacterium tuberculosis and is an agent for standard prophylaxis against the recurrence of bladder cancer. Unfortunately, it can cause severe infectious diseases, especially in immunocompromised patients, and the ability to immediately distinguish BCG from other M. tuberculosis complexes is therefore important. In this study, we developed a simple and easy-to-perform identification procedure using loop-mediated amplification (LAMP) to detect deletions within the region of difference, which is deleted specifically in all M. bovis BCG strains. Reactions were performed at 64 °C for 30 min and successful targeted gene amplifications were detected by real-time turbidity using a turbidimeter and visual inspection of color change. The assay had an equivalent detection limit of 1.0 pg of genomic DNA using a turbidimeter whereas it was 10 pg with visual inspection, and it showed specificity against 49 strains of 44 pathogens, including M. tuberculosis complex. The expected LAMP products were confirmed through identical melting curves in real-time LAMP procedures. We employed the Procedure for Ultra Rapid Extraction (PURE) kit to isolate mycobacterial DNA and found that the highest sensitivity limit with a minimum total cell count of mycobacterium (including DNA purification with PURE) was up to 1 × 10(3) cells/reaction, based on color changes under natural light with FDA reagents. The detection limit of this procedure when applied to artificial serum, urine, cerebrospinal fluid, and bronchoalveolar lavage fluid samples was also about 1 × 10(3) cells/reaction. Therefore, this substitute method using conventional culture or clinical specimens followed by LAMP combined with PURE could be a powerful tool to enable the rapid identification of M. bovis BCG as point-of-care testing. It is suitable for practical use not only in resource-limited situations, but also in any clinical situation involving immunocompromised patients because of its convenience, rapidity, and cost effectiveness.


Assuntos
Técnicas de Tipagem Bacteriana/métodos , DNA Bacteriano/genética , Mycobacterium bovis/genética , Tuberculose/microbiologia , Vacina BCG/efeitos adversos , Sequência de Bases , Líquidos Corporais/microbiologia , Colorimetria , Primers do DNA , Diagnóstico Diferencial , Genes Bacterianos , Humanos , Dados de Sequência Molecular , Mycobacterium bovis/isolamento & purificação , Mycobacterium tuberculosis/genética , Nefelometria e Turbidimetria , Técnicas de Amplificação de Ácido Nucleico/métodos , Desnaturação de Ácido Nucleico , Testes Imediatos , Sensibilidade e Especificidade , Alinhamento de Sequência , Homologia de Sequência do Ácido Nucleico , Especificidade da Espécie , Temperatura , Tuberculose/diagnóstico , Tuberculose/etiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA